Stockscreener 앱 받기
82.41
1.82%
1.47
시간 외 거래:
82.33
-0.08
-0.10%
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Will FDA Bitopertin Rejection and New Legal Probe Change Disc Medicine's (IRON) Narrative? - Sahm
Disc (IRON) Quarterly Figures: EPS Exceeds Its Estimate for the Current Session; Price Reaction: Shares Move 1.84% Lower in the Available RecordQuarterly Earnings - vinanet.vn
Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade
Handelsbanken Fonder AB Buys Shares of 12,700 Disc Medicine, Inc. $IRON - MarketBeat
Disc (IRON) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Trading Move - vinanet.vn
Disc Medicine CEO John Quisel sells $2.6m in shares By Investing.com - Investing.com Australia
Disc Medicine CEO John Quisel sells $2.6m in shares - Investing.com
Disc Medicine CEO John D. Quisel disposes of USD 2.63 million in common shares - Bitget
Insider Selling: Disc Medicine (NASDAQ:IRON) CEO Sells 33,000 Shares of Stock - MarketBeat
Disc Medicine (IRON) CEO sells 33K shares under trading plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
GSA Capital Partners LLP Takes $1.19 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine faces class action after FDA reje... - Pluang
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
Disc Medicine (NASDAQ: IRON) insider to sell 33,000 shares via plan - Stock Titan
Disc Medicine (IRON) Pulls Back 1.46% to $78.84 as Shares Test Key Resistance ZoneExhaustion Gap - vinanet.vn
Disc Medicine (IRON) Slips 1.46% as Biotech Consolidates Near Key SupportCovered Call ETF - Vinanet
Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com - Investing.com Australia
Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares - MarketBeat
Disc Medicine COO Jonathan Yu sells $66,444 in shares - Investing.com
Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Sei Investments Co. Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
FMR LLC Trims Disc Medicine Inc (IRON) Stake: A Strategic Reduction Amid Biotech Volatility - GuruFocus
Disc Medicine, Inc. (IRON) Investor Outlook: Potential 29% Upside Ignites Interest - DirectorsTalk Interviews
Renaissance Technologies LLC Sells 31,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Price-Driven Insight from (IRON) for Rule-Based Strategy - Stock Traders Daily
The Manufacturers Life Insurance Company Decreases Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Shares Sold by Assenagon Asset Management S.A. - MarketBeat
HC Wainwright Decreases Earnings Estimates for Disc Medicine - MarketBeat
Disc Medicine Inc (IRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares By Investing.com - Investing.com Australia
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares - Investing.com
Disc Medicine (NASDAQ:IRON) Insider Rahul Khara Sells 5,000 Shares - MarketBeat
Disc Medicine Chief Legal Officer Rahul Khara disposes of 5,000 common shares for $400,000 - Bitget
Disc Medicine Insider Sold Shares Worth $400,000, According to a Recent SEC Filing - Moomoo
Disc Medicine (NASDAQ: IRON) CLO sells 5,000 shares after option exercise - Stock Titan
FY2029 EPS Estimates for Disc Medicine Lowered by Analyst - marketbeat.com
IRON (IRON) filer plans 5,000-share stock sale after option exercise - Stock Titan
Disc Medicine (IRON): FMR LLC, Abigail Johnson report 12.8% ownership of common stock - Stock Titan
HC Wainwright Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
IRON Maintained by HC Wainwright & Co. -- Price Target Raised to $120 - GuruFocus
H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $120 - Moomoo
Dimensional Fund Advisors LP Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Slips 1.86% as Biotech Stock Tests Key Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Disc Medicine, Inc. Revenue Breakdown – NASDAQ:IRON - TradingView
Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 32% Potential Upside with Strong Buy Ratings - directorstalkinterviews.com
Lazard Asset Management LLC Lowers Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Bank of New York Mellon Corp Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
How Investors Are Reacting To Disc Medicine (IRON) Balancing Larger Losses With APOLLO Phase 3 FDA Alignment - simplywall.st
0.07%
1.21%
자본화:
|
볼륨(24시간):